Table 5 Survival analysis on all case by Log-rank analysis (n = 121)
From: Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
Parameters | Grouping | Case number (n/%) | χ2value | df | P value |
|---|---|---|---|---|---|
Tumor diameter (cm) | <5 | 48/(39.7) | 9.190 | 1 | 0.002 |
≥5 | 73/(60.3) | ||||
Tumor location | Cardia, fundus | 20/(16.5) | 8.122 | 2 | 0.017 |
Body | 37/(30.6) | ||||
Pylorus, antrum | 64/(52.9) | ||||
Invasion depth | T1 | 18/(14.9) | 11.712 | 3 | 0.008 |
T2 | 32/(26.4) | ||||
T3 | 30/(24.8) | ||||
T4 | 41/(33.9) | ||||
Involving lymph node station | N0 | 43/(35.5) | 24.017 | 3 | <0.001 |
N1 | 41/(33.9) | ||||
N2 | 26/(21.5) | ||||
N3 | 11/(9.1) | ||||
Metastatic lymph node ratio | <35% | 60/(49.6) | 8.596 | 1 | 0.003 |
≥35% | 61/(50.4) | ||||
TNM stage | Ia | 16/(13.2) | 25.405 | 5 | <0.001 |
Ib | 17/(14.0) | ||||
II | 20/(16.5) | ||||
IIIa | 20/(16.5) | ||||
IIIb | 22/(18.2) | ||||
IV | 26/(21.5) | ||||
c-MET expression | Positive | 80/(66.1) | 12.084 | 1 | 0.001 |
Negative | 41/(33.9) | ||||
p-MET expression | Positive | 72(59.5) | 5.687 | 1 | <0.001 |
Negative | 49(40.5) | ||||
e2f-1 expression | Positive | 47/(38.8) | 3.217 | 1 | 0.036 |
Negative | 74/(61.2) | ||||
Ki-67 expression | Positive | 88/(72.7) | 9.348 | 1 | 0.002 |
Negative | 33/(27.3) |